Overview

Long-Term Treatment With rhIGF-1 in GHIS

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Long term study of the effects of dosing with rhIGF-1 on growth
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ipsen
Collaborator:
University of Oklahoma
Treatments:
Mecasermin